Scinvivo Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 9

Scinvivo General Information

Description

Developer of a minimally invasive imaging platform designed to advance cancer diagnostics and care. The company's technology provides real-time visualization of subsurface tissue structures during endoscopic procedures, addressing limitations of conventional imaging methods and enabling medical professionals to improve diagnostic accuracy and treatment outcomes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Torenallee 20
  • 5617 BC Eindhoven
  • Netherlands
+31 06
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • Torenallee 20
  • 5617 BC Eindhoven
  • Netherlands
+31 06

Scinvivo Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Scinvivo Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Accelerator/Incubator 30-Oct-2025 Completed Generating Revenue
5. Later Stage VC (Series A) 21-Feb-2024 Completed Generating Revenue
4. Seed Round 10-Mar-2022 Completed Pre-Clinical Trials
3. Accelerator/Incubator 22-Dec-2021 Completed Startup
2. Accelerator/Incubator 08-Oct-2019 Completed Pre-Clinical Trials
1. Seed Round 22-Mar-2017 Completed Startup
To view Scinvivo’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Scinvivo Patents

Scinvivo Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4522936-A1 Optical coherence tomography system and method Pending 10-May-2022
US-12768640-B2 Optical coherence tomography system and method Active 10-May-2022
US-20250297850-A1 Optical coherence tomography system and method Active 10-May-2022
WO-2023219501-A1 Optical coherence tomography system and method Inactive 10-May-2022
EP-3761858-A1 Mems mirror for oct probe and method of manufacturing such mems mirror Active 09-Mar-2018 G02B26/0841
To view Scinvivo’s complete patent history, request access »

Scinvivo Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Scinvivo Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Texas Medical Center Venture Capital Minority
Rijksdienst voor Ondernemend Nederland Government Minority
Santec OIS Corporation Corporation Minority
Innovatiefonds Noord-Holland Venture Capital Minority
Reno Seed Advisors Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Scinvivo FAQs

  • When was Scinvivo founded?

    Scinvivo was founded in 2016.

  • Where is Scinvivo headquartered?

    Scinvivo is headquartered in Eindhoven, Netherlands.

  • What is the size of Scinvivo?

    Scinvivo has 8 total employees.

  • What industry is Scinvivo in?

    Scinvivo’s primary industry is Diagnostic Equipment.

  • Is Scinvivo a private or public company?

    Scinvivo is a Private company.

  • What is Scinvivo’s current revenue?

    The current revenue for Scinvivo is .

  • How much funding has Scinvivo raised over time?

    Scinvivo has raised $6.2M.

  • Who are Scinvivo’s investors?

    Texas Medical Center, Rijksdienst voor Ondernemend Nederland, Santec OIS Corporation, Innovatiefonds Noord-Holland, and Reno Seed Advisors are 5 of 9 investors who have invested in Scinvivo.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process